Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States.
about
Rhabdomyolysis: a manifestation of cyclobenzaprine toxicityCarisoprodol use and abuse in Norway: a pharmacoepidemiological studyCarisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studiesCOMParative Early Treatment Effectiveness between physical therapy and usual care for low back pain (COMPETE): study protocol for a randomized controlled trialThe societal costs of low back pain: data published between 2001 and 2007.Abuse Potential of Soma: the GABA(A) Receptor as a TargetConsiderations for the appropriate use of skeletal muscle relaxants for the management of acute low back painTranslating evidence for low back pain management into a consumer-focussed resource for use in community pharmacies: a cluster-randomised controlled trialAntineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic reviewTime to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States.Painful Ejaculation with Cyclobenzaprine: A Case Report and Literature ReviewEfficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis.[Methocarbamol in acute low back pain. A randomized double-blind controlled study].Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults.Carisoprodol tolerance and precipitated withdrawal.A Single Amino Acid Residue at Transmembrane Domain 4 of the α Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA Receptors.
P2860
Q21203721-7165F75F-B7AA-47F3-85B4-8984558B0ED8Q24564756-F8626C8A-3ECE-44B6-8955-EDD47DC2EAB0Q24655305-DA3D1E00-E0A5-4522-85D3-99FAB6D569C1Q28389441-5060EEA7-628E-4A78-803C-8320A6EAC8D2Q31137445-FA10738C-3B29-4760-8737-1E16D9D3BCC5Q33805864-521A8BE5-AAEF-44CE-A6AB-245CEDC63194Q33920873-E7345A93-BE79-4424-993C-71CF6DE4B9C1Q34972661-C8CEEE55-24FA-4CF0-9768-496BF89E7450Q35955249-6A2DBA65-C4FD-4D9A-B949-0D071A99082CQ37975301-09CF711F-79DB-4239-AC20-747C087E3D68Q38706939-DFF9F84C-EFB9-4006-82EB-BE27734F527AQ38872658-C7806C0B-1CD7-4F36-813C-9279573E97E7Q39186470-C6B8096F-61A2-4204-BDC8-18F2D8317939Q39272459-56C7ABFC-75C0-424F-B054-C1D30BDC7742Q42631946-BF5C794A-AA1C-40FC-B318-208185651317Q45061898-2EFEBA43-6158-4FAA-832E-2A3C8F244A72
P2860
Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prescription of nonsteroidal a ...... ack pain in the United States.
@ast
Prescription of nonsteroidal a ...... ack pain in the United States.
@en
type
label
Prescription of nonsteroidal a ...... ack pain in the United States.
@ast
Prescription of nonsteroidal a ...... ack pain in the United States.
@en
prefLabel
Prescription of nonsteroidal a ...... ack pain in the United States.
@ast
Prescription of nonsteroidal a ...... ack pain in the United States.
@en
P2093
P1433
P1476
Prescription of nonsteroidal a ...... ack pain in the United States.
@en
P2093
Lesley H Curtis
Lloyd A Hey
Xuemei Luo
P304
P356
10.1097/01.BRS.0000146453.76528.7C
P407
P577
2004-12-01T00:00:00Z